Demand for triacetonamine derivatives (TAA derivatives) has kept rising for several years. Evonik Industries is taking advantage of the economic opportunities afforded by this situation and is considerably expanding its production capacities for these special derivatives in China. The foundations for a new plant will be laid as early as this year.

Currently, Evonik produces the derivatives in a joint venture Evonik Tianda (Liaoyang) Chemical Additive at the Liaoyang site in northeastern China. The existing production capacities are to be moved within the Liaoyang region to the Aromatic Site (LAS), one of the country's largest petrochemical sites. Furthermore, production will be significantly increased. Full production is scheduled to commence in the fourth quarter of 2011.